These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 11165111)
21. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Wiesemann HG; Steinkamp G; Ratjen F; Bauernfeind A; Przyklenk B; Döring G; von der Hardt H Pediatr Pulmonol; 1998 Feb; 25(2):88-92. PubMed ID: 9516091 [TBL] [Abstract][Full Text] [Related]
22. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients. Richards RM; Hamilton VE; Thomas MR J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834 [TBL] [Abstract][Full Text] [Related]
23. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Greally P; Whitaker P; Peckham D Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602 [TBL] [Abstract][Full Text] [Related]
24. Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa. Vickery SB; McClain D; Wargo KA Pharmacotherapy; 2016 Oct; 36(10):e154-e159. PubMed ID: 27522066 [TBL] [Abstract][Full Text] [Related]
25. Treatment of pseudomonas and Staphylococcus bronchopulmonary infection in patients with cystic fibrosis. Das RR; Kabra SK; Singh M ScientificWorldJournal; 2013; 2013():645653. PubMed ID: 24489509 [TBL] [Abstract][Full Text] [Related]
26. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. Hansen CR; Pressler T; Høiby N J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078 [TBL] [Abstract][Full Text] [Related]
27. The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis. Ramsay KA; Sandhu H; Geake JB; Ballard E; O'Rourke P; Wainwright CE; Reid DW; Kidd TJ; Bell SC J Cyst Fibros; 2017 Jan; 16(1):70-77. PubMed ID: 27515017 [TBL] [Abstract][Full Text] [Related]
29. How to use: bacterial cultures in diagnosing lower respiratory tract infections in cystic fibrosis. Ahmed B; Bush A; Davies JC Arch Dis Child Educ Pract Ed; 2014 Oct; 99(5):181-7. PubMed ID: 24334311 [TBL] [Abstract][Full Text] [Related]
30. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance]. Coman G; Petraru E; Dahorea C; Anton DT Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957 [TBL] [Abstract][Full Text] [Related]
34. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233 [TBL] [Abstract][Full Text] [Related]